Fairfax Northern Virginia Hematology Oncology, Fairfax, VA.
J Oncol Pract. 2009 Nov;5(6):287-90. doi: 10.1200/JOP.091036.
Although nodal status, grade, size, and receptor status play roles in determining breast cancer prognosis, there is increasing evidence that maintaining dose intensity of adjuvant chemotherapy increases disease-free survival rate.
虽然淋巴结状态、分级、大小和受体状态在确定乳腺癌预后方面起作用,但越来越多的证据表明维持辅助化疗的剂量强度可以提高无病生存率。